University of Southern California
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Southern California sits in the top decile of US sponsors by registered trial count (#55 of 15,742 sponsors by registered trial count).
University of Southern California: 617 sponsored US clinical trials, 97 recruiting.
University of Southern California sponsors 617 registered US clinical trials on ClinicalTrials.gov, 97 of them currently recruiting, and 361 completed. 31 of these trials are in Phase 3-4 (later-stage) and 173 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 6 trials.
Top-decile sponsor footprint
University of Southern California ranks in the top decile of sponsors by registered trial count (#55 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
361 of 466 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (77.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
617 total, page 8 of 13
The Effects of Natural Sugars in Breast Milk on Healthy Infant Growth and Development
NCT04434027
Effects of Intranasal Oxytocin on Cigarette Smoking
NCT02595749
Musculoskeletal Health of the Upper Extremity in Emerging Health Professionals
NCT02587897
Fish Oil Brain Delivery Study
NCT02541929
Cell-Free DNA and RNA in Blood fromMetastatic Prostate Cancer Patients
NCT02853097
Perceptions of Side Effects of Cancer Chemoradiotherapy
NCT02978846
Change the Cycle: An RCT to Prevent Injection Initiation
NCT02774954
Movement Tracking Devices to Monitor Physical Activity in Patients Undergoing Chemotherapy
NCT03098277
Robotic or Open Radical Cystectomy in Treating Patients With Bladder Cancer
NCT02699853
Randomized Trial of Wire and Sphincterotome Systems for Biliary Cannulation
NCT02197338
Rehabilitation: Closed-Chain Exercises for Rotator Cuff Tears
NCT02750176
MDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder Cancer
NCT02735512
Neural Mechanisms for Appetitive Responses to High Reward Foods
NCT02945475
The Effect of Aging on Value Based Decision-making
NCT03341611
Sitagliptin Effects on Arterial Vasculature and Inflammation in Obesity
NCT02576288
¡Vivir Mi Vida! Pilot Study
NCT04623489
PUBMIC (Prophylactic Use of Biologic Mesh in Ileal Conduit)
NCT02439060
Women's Treatment and Early Recovery
NCT02977988
High-Intensity Interval Training for Stage I-III Breast Cancer Patients
NCT02454777
Ultrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder Cancer
NCT02494635
Longitudinal Evaluation of Amyloid Risk and Neurodegeneration - the LEARN Study
NCT02488720
Steady-state Pharmacokinetics of Ceftazidime/Avibactam in Cystic Fibrosis
NCT02504827
Golf for Veterans Study
NCT04004598
Wild-Type Reovirus, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
NCT02514382
Supportive Care Questionnaires in Gathering Data on Unmet Needs and Health-Related Quality of Life in Latina Breast Cancer Survivors After Surgery, Chemotherapy, or Radiation Therapy
NCT02545023
Protease Inhibitors and Combined Oral Contraceptive Pharmacokinetics and Pharmacodynamics
NCT02531321
Pharmacokinetics of Tedizolid Phosphate in Cystic Fibrosis
NCT02444234
Modeling and Testing Change in Mental Abilities in Childhood
NCT02459873
Probiotics and the Gut Microbiome in Obese Hispanic Youth
NCT03115385
Sensory Adapted Dental Environments to Enhance Oral Care for Children
NCT02430051
Clinical Effectiveness of Late Maxillary Protraction for Cleft Lip and Palate
NCT02789787
Patient Navigation and Tailored Treatment Planning in Latina Patients With Breast Cancer
NCT02483377
Collaborative Connected Health (CCH) for PCORI
NCT02358135
A Two-step Training Paradigm for Voluntary Control of the Peri-auricular Muscles
NCT02358915
Real-Time Contrast-Enhanced Ultrasonography and Shear Wave Elastography in Predicting Treatment Response in Patients With Soft Tissue Sarcoma
NCT02384473
Molecular Characterization of CTCs and ctDNA in Blood and Plasma Samples From Patients With Metastatic and/or Hormone-Resistant Prostate Cancer
NCT02370355
Effects of Chemotherapy on Intestinal Bacteria in Patients With Newly Diagnosed Breast Cancer
NCT02370277
Aquaresis Utility for Hyponatremic Acute Heart Failure Study
NCT02183792
Celiac Plexus Block for Chronic Pancreatitis RCT
NCT02399800
Facilitated Release of Endogenous Enterokines
NCT04215328
Lavender Aromatherapy for Anxiety During Urodynamics
NCT02344745
Resilient, Empowered, Active Living: REAL Diabetes Study
NCT02214641
Primary Care Providers' Views and Understanding of Current Recommended Guidelines for Cervical Cancer Screening
NCT02265120
Phenelzine Sulfate in Treating Patients With Non-metastatic Recurrent Prostate Cancer
NCT02217709
Healthy Moms-Healthy Kids: Reducing Maternal Depression for Better Outcomes in Head Start Children
NCT02145273
Allopregnanolone for Mild Cognitive Impairment Due to Alzheimer's Disease or Mild AD
NCT02221622
Mind-Body Training for Hand Rehabilitation
NCT02459847
Ovulation Incidence in Oral Contraceptive Users
NCT03106454
Comprehensive Genomic Analysis in Tissue and Blood Samples From Young Patients With Lung Cancer
NCT02273336
Cancer Genetics Hereditary Cancer Panel Testing
NCT02324062
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 83 |
| Phase 2 | 90 |
| Phase 3 | 9 |
| Phase 4 | 22 |
Therapeutic Areas
What is open in the University of Southern California pipeline
97 recruiting of 617 indexed (16% open); 361 completed (59%).
Phase mix: 31 late (III/IV) vs 173 early (I/II) (early-phase heavy).
Top condition: Obesity (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Southern California: open-pipeline peers nationwide
Peers matched on 617 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of Southern California sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 617 trials (± recruiting share)
- Baylor College of Medicine · 616 trials · 15% recruiting
- US Department of Veterans Affairs · 632 trials · 0% recruiting
- University of Rochester · 636 trials · 15% recruiting
- Janssen Research & Development · 593 trials · 11% recruiting
Sponsors near 16% open enrollment (± trial volume)
- Youngstown State University · 16% recruiting · 19 trials
- Roswell Park Cancer Institute · 16% recruiting · 365 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- University of Oregon · 16% recruiting · 63 trials
Related
What to do with this University of Southern California page
617 registered trials is a research-attention snapshot, not an endorsement of University of Southern California or any single study.
- 97 of University of Southern California's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Southern California studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Southern California pipeline card: 617 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.